Funding for this research was provided by:
Academy of Medical Sciences
Rosetrees Trust (M369)
Addenbrooke's Charitable Trust, Cambridge University Hospitals (PF15/CWG)
Medical Research Council (MR/R007446/1)
Stevenage Biosciences Catalyst Open Innovation Challenge in Neurodegenerative disease
NIHR Cambridge Biomedical Research Centre
Wellcome-MRC Cambridge Stem Cell Institute
Text and Data Mining valid from 2018-05-28
Received: 14 March 2018
Accepted: 16 May 2018
First Online: 28 May 2018
Ethics approval and consent to participate
: This study was approved by the East of England—Cambridge Central Research Ethics Committee (ref 03/303). All participants provided written informed consent.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.